Monday, March 17, 2025 | 01:42 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Dr Reddys Laboratories announces launch of generic Azacitidine for Injection

Image

Capital Market

In Canada

Dr Reddys Laboratories announced that generic Azacitidine for Injection 100mg/vial, bioequivalent generic version of VIDAZA, is approved by Health Canada. VIDAZA is trademark of Celgene.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 02 2017 | 7:47 PM IST

Explore News